Shi Yin

Mr. Shi Yin

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2023 in Cancer Medicine
Verified
Journal Article
Open access
FZFengxiang Zhang
Fengxiang Zhang
HCHuaxian Chen
Huaxian Chen
DLDandong Luo
Dandong Luo
ZXZhizhong Xiong
Zhizhong Xiong
XLXianzhe Li
Xianzhe Li
SYShi Yin
Shi Yin
Background: Lymphovascular invasion (LVI) and perineural invasion (PNI) are associated with poorer prognosis in several human malignancies, but their significance in gastric cancer (GC) remains to be clearly defined. Our study aimed to investigate the prognostic value of LVI/PNI in patients with curative resected GC.Methods: Records of 1488 patients with stage I‐–III GC and 3327 patients with stage I–III colorectal cancer (CRC) were reviewed retrospectively, and difference in the incidence of LVI/PNI between GC and CRC was compared. Univariate and multivariate analyses were used to evaluate whether LVI/PNI was an independent risk factor for lymph node metastasis (LNM) and overall survival (OS) in GC.Results: Patients with stage I–III GC had a significantly higher incidence of LVI/PNI than patients with stage I–III CRC (50.54% vs. 21.91%, p < 0.001). LVI/PNI was significantly associated with higher CEA, higher CA199, deeper tumor invasion, more lymph node metastasis, and advanced TNM stage in GC ( p < 0.05). Multivariate logistic regression analysis identified LVI/PNI (OR = 2.64, 95%CI: 2.05–3.40, p < 0.001) as an independent risk factor for LNM in GC. The OS rate was significantly lower in the LVI/PNI‐positive GC group than that in the LVI/PNI‐negative GC group ( p < 0.001). On multivariate Cox regression analysis, LVI/PNI (HR = 1.34, 95%CI: 1.04–1.71, p = 0.023) was an independent prognostic factor for OS in GC.Conclusion: GC has a high incidence of LVI/PNI, which was closely associated with disease progression. LVI/PNI could serve as an independent risk factor for LNM and the prognosis of patients with curative resected GC. These findings will be helpful in predicting survival outcomes more accurately and establishing individualized treatment plans.

27 April 2018 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
SYShi Yin
Shi Yin
QHQunsheng Huang
Qunsheng Huang
LZLongjuan Zhang
Longjuan Zhang
HQHuabo Qin
Huabo Qin
XHXiaosheng He
Xiaosheng He
PLPing Lan
Ping Lan

22 December 2018 in Gastroenterology Report
Verified
Journal Article
Open access
QHQunsheng Huang
Qunsheng Huang
HQHuabo Qin
Huabo Qin
JXJian Xiao
Jian Xiao
XHXiaosheng He
Xiaosheng He
MXMinghao Xie
Minghao Xie
SYShi Yin
Shi Yin
Background and objective: Neoadjuvant chemoradiation therapy (NCRT) followed by radical resection has been a common practice for patients with locally advanced rectal cancer. This study aimed to analyse the association of tumor differentiation and prognosis in rectal-cancer patients undergoing NCRT. Methods: Patients with locally advanced, non-mucinous rectal cancer who underwent NCRT followed by radical resection between 2007 and 2017 were identified from an electronic health record system at the Sixth Affiliated Hospital of Sun Yat-sen University (Guangzhou, China). Multivariable logistic regression and multivariate Cox regression were performed to analyse the association of response to NCRT and survival with clinicopathological characteristics of all these patients. Results: We identified 325 patients (241 males and 84 females; mean age, 54.4 ± 11.2 years) who underwent NCRT followed by radical resection, including 26 (8.0%) with poorly-differentiated rectal cancer, 182 (56.0%) with moderately-differentiated cancer and 117 (36.0%) with well differentiated cancer. Propensity score matching analysis and multivariable logistic regression analysis results showed that tumor differentiation was significantly associated with response to NCRT. In the poor differentiation and non-poor differentiation groups, the 3-year overall survival (OS) rates were 74.6 and 93.5%, respectively, whereas the 3-year local recurrence rates were 18.6 and 3.7%, respectively. Multivariable Cox regression analyses revealed that poor differentiation was an independent risk factor for local recurrence and OS. Conclusions: Among the patients with locally advanced, non-mucinous rectal cancer, the patients with poorly-differentiated cancer who underwent NCRT had a worse response to NCRT and poorer prognosis than those with moderately- and well-differentiated diseases.

6 August 2008 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
SYShi Yin
Shi Yin
ZSZuzana Serclova
Zuzana Serclova
VFVictor W. Fazio
Victor W. Fazio
RKRavi P. Kiran
Ravi P. Kiran
FRFeza Remzi
Feza Remzi
BSBo Shen
Bo Shen

24 June 2021 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
LJLongyang Jin
Longyang Jin
CHChao Han
Chao Han
TZTianyu Zhai
Tianyu Zhai
XZXiaoyu Zhang
Xiaoyu Zhang
CCChun Chen
Chun Chen
SYShi Yin
Shi Yin
Colorectal cancer (CRC) is one of the most common malignancies worldwide. Circular RNAs (circRNAs) are involved in pathological processes, especially in the development of cancers, but the roles of circRNAs in CRC are largely unknown. In this study, we investigated the role and underlying mechanisms of Circ_0030998 in CRC cell proliferation and angiogenesis. We found that Circ_0030998 was upregulated in CRC tissues and cells, and its upregulation was related to poor prognosis in CRC patients. Circ_0030998 promoted CRC cell proliferation in vitro and in vivo, and facilitated the angiogenesis of HUVECs. Mechanistic studies demonstrated that Circ_0030998 acted as a miR-567 sponge to relieve its inhibitory effect on VEGFA. Rescue assays validated that Circ_0030998 functioned in CRC cell proliferation and angiogenesis relying on VEGFA. Our findings clarified the Circ_0030998/miR-567/VEGFA regulation axis and indicated that Circ_0030998 could be a potential therapeutic target for CRC.

26 July 2025 in BMC Cancer
Verified
Journal Article
Open access
PDF file
YCYonghe Chen
Yonghe Chen
DLDan Liu
Dan Liu
ZWZhong Wang
Zhong Wang
YLYi Lin
Yi Lin
XJXiaohan Jiang
Xiaohan Jiang
SYShi Yin
Shi Yin
Static carcinoembryonic antigen (CEA) levels are well‑established prognostic markers in patients with gastric cancer, but the significance of their dynamic trajectories over time has rarely been reported. We analysed the perioperative CEA levels (presurgery, early postsurgery, and late postsurgery) of 578 gastric cancer patients who underwent curative resection, with a median follow-up of 29 months. We used the entire cohort for k-means clustering. Survival differences between clusters were assessed using Kaplan–Meier analysis and Cox regression. Of the 578 patients, 15.57% exhibited elevated CEA levels before surgery (median 2.07 ng/mL), which then decreased to 3.29% (median 1.74 ng/mL) after surgery. However, after six months, a slight rebound was observed (18.51% elevated, median 2.98 ng/mL). K-means clustering identified three CEA trajectories: high, medium, and low (Calinski–Harabasz index: 358). Survival analysis demonstrated that higher CEA trajectories were associated with worse disease-free survival (DFS) and overall survival (OS). With the low cluster as a reference, multivariate Cox regression analysis revealed that a higher CEA trajectory was an independent prognostic factor, with an elevated risk in the high cluster (HR 2.64, 95% CI: 1.37-5.0), indicating that the high cluster had more than twice the mortality risk of the low cluster and that the medium cluster had a moderately increased mortality risk (HR 1.69, 95% CI: 1.0-2.85). Higher CEA trajectories are associated with a worse prognosis, highlighting the importance of enhanced monitoring for this group of patients. A machine learning-powered trajectory clustering algorithm employed. The trajectory cluster classification demonstrates a strong correlation with both disease-free survival and overall survival.